ClinConnect ClinConnect Logo
Search / Trial NCT06754319

Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis

Launched by SHANGHAI MENTAL HEALTH CENTER · Dec 23, 2024

Trial Information

Current as of September 11, 2025

Enrolling by invitation

Keywords

Microbiota Gut Brain Axis Pediatric Ocd Microbiome

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • We recruited outpatient children and adolescents with OCD confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (4th edition). The following inclusion and exclusion criteria were also applied:
  • Inclusion Criteria:
  • (1) 7-17 years old, (2) Y-BOCS score ≥16, (3) with or without a history of TD, (4) Drug-naïve or drug-free for 8 weeks, (5) Wechsler IQ score ≥ 80.
  • Exclusion Criteria:
  • History of serious medical, neurological illness or other psychotic disorders other than OCD (tic disorder excepted).
  • Previous exposure to cognitive behavioral therapy (CBT) for OCD or TD.
  • serious suicide risk.
  • Has taken antibiotics, probiotics, prebiotics, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immunosuppressants within the past 8 weeks.
  • Has a history of gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome, constipation, hemorrhoids, or a history of gastrointestinal surgery, or has a history of autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus.
  • Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.

About Shanghai Mental Health Center

Shanghai Mental Health Center is a leading institution dedicated to advancing mental health research and treatment. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and evidence-based practices to address a wide range of psychiatric disorders. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to enhancing patient care through rigorous clinical trials that contribute to the understanding and management of mental health conditions. Its mission is to foster collaboration among researchers, clinicians, and patients to promote mental well-being and improve outcomes in mental health care.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Trial Officials

Zhen Wang, PhD, MD

Principal Investigator

Shanghai Mental Health Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported